Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 9Phase 1/2 4Phase NA 3Phase EARLY_PHASE1 2Phase 3 2Phase 4 1Phase 2/3 1

Status

Completed 14Recruiting 9Active not recruiting 6Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 2Endocrine 2

Conditions

Carcinoma, Non-Small-Cell Lung 92Breast Neoplasms 86Neoplasms 79Prostatic Neoplasms 50Lung Neoplasms 44Neoplasm Metastasis 40Colorectal Neoplasms 37Leukemia, Myeloid, Acute 32Pain 27Head and Neck Neoplasms 25Colonic Neoplasms 25Multiple Myeloma 24Ovarian Neoplasms 23Lymphoma 23Carcinoma, Hepatocellular 23Pancreatic Neoplasms 22Lymphoma, Follicular 21Melanoma 20Leukemia 20Rectal Neoplasms 19Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 17Recurrence 17Stomach Neoplasms 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Squamous Cell Carcinoma of Head and Neck 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leiomyoma 13

Interventions

Somatostatin 1Serotonin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Neuroendocrine Tumors × Clear all
NCT00227136 2018-04-13

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

Western University, Canada

Phase 3 Terminated
8 enrolled
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT01755182 2016-05-06

LOTUS

National Cancer Institute, Naples

Phase 3 Terminated
1 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡